Queensbury, NY, United States of America

Daniel Charles Stewart

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Charles Stewart

Introduction

Daniel Charles Stewart is an accomplished inventor based in Queensbury, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on the development of innovative bortezomib compositions, which have important therapeutic applications.

Latest Patents

Among his latest patents, Stewart has developed ready-to-use liquid aqueous bortezomib compositions. These compositions include bortezomib and various pharmaceutical excipients. The patents also detail methods for preparing these ready-to-use liquid formulations and their applications in therapeutic settings. This innovation is crucial for enhancing the efficacy and convenience of bortezomib treatments.

Career Highlights

Stewart's career is marked by his dedication to advancing pharmaceutical science. His work at Maia Pharmaceuticals, Inc. has positioned him as a key player in the development of effective cancer therapies. His innovative approaches have garnered attention in the industry, contributing to the ongoing evolution of treatment options for patients.

Collaborations

Stewart collaborates with talented professionals in his field, including his coworker Srikanth Sundaram. Together, they work on projects that aim to improve patient outcomes through innovative pharmaceutical solutions.

Conclusion

Daniel Charles Stewart's contributions to the field of pharmaceuticals, particularly in the development of bortezomib compositions, highlight his role as a significant inventor. His work continues to impact therapeutic applications, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…